HTA Consumer Consultative Committee
RoleThe HTA Consumer Consultative Committee (the Committee) was established in 2017 to provide strategic advice and support to the principal Health Technology Assessment Committees and the Department of Health. The Committee work plan has included activities especially relating to consumer engagement and participation in Health Technology Assessment processes.
The Committee’s key functions are to:
- Assist the Department to work more closely with consumers and communities in HTA decision making
- Bring consumer and community evidence and views into HTA processes
- Inform policy on consumer and patient matters in HTA of significance to Australian consumers and community
- Creating opportunities to promote greater public understanding of HTA processes
- Enhance methods for formal patient inputs.
For more detail, please see:
- Membership of the Committee includes consumer representatives from the TGA, PBAC, MSAC, PLAC and their related sub-committees.
- CCC Communique - 13 November 2020 (PDF 105 KB) - (Word 21 KB)
- CCC Communique - 21 July 2020 (PDF 86 KB) - (Word 20 KB)
- CCC Communique – 31 March 2020 (PDF 207 KB) - (Word 22 KB)
- CCC Communique – 17 October 2019 (PDF 105 KB) - (Word 20 KB)
- CCC Communique - 25 June 2019 (PDF 212 KB) - Word 20 KB
- CCC Communique - 27 March 2019 (PDF 235 KB) - (Word 23 KB)
- CCC Communique - 12 November 2018 (PDF 249 KB) - (Word 20 KB)
- CCC Communique - 13 August 2018 (PDF 191 KB) - (Word 18 KB)
- CCC Communique - 14 May 2018 (PDF 90 KB) - (Word 18 KB)
- CCC Communique - 12 February 2018 (PDF 104 KB) - (Word 16 KB)
- CCC Communique - August 2017 (PDF 67 KB) - (Word 24 KB)
- CCC Communique - October 2017 (PDF 65 KB) - (Word 29 KB)
- CCC Communique - December 2017 (PDF 64 KB) - (Word 29 KB)
Page currency, Latest update: 16 February, 2021